Adaptin Bio (APTN) Payables (2022 - 2026)

Adaptin Bio has disclosed Payables across 5 years of filings, most recently posting $1.4 million for Q1 2026.

• Quarterly Payables rose 319.29% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 319.29% YoY) and the FY2025 annual result came in at $1.5 million, down 7.58% from the prior year.
• Payables fell to $1.4 million in Q1 2026, from $1.5 million in the prior quarter.
• Across five years, Payables topped out at $1.6 million in Q4 2024 and bottomed at $12804.0 in Q4 2022.
• The 5-year median for Payables is $258973.5 (2024), against an average of $623934.7.
• Year-over-year, Payables surged 1912.97% in 2024 and decreased 7.58% in 2025.
• Adaptin Bio's Payables stood at $12804.0 in 2022, then surged by 534.78% to $81277.0 in 2023, then surged by 1912.97% to $1.6 million in 2024, then dropped by 7.58% to $1.5 million in 2025, then decreased by 9.31% to $1.4 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.